Introduction
It is a bizarre fact that the intake of large amounts of fat can, under certain circumstances, improve health. The ketogenic diet (KD) is an example of a health-improving, high-fat diet applied in cases of epilepsy. Close monitoring is essential. Several monitoring methods exist, each with its own short-comings.
The KD is used in children with refractory epilepsy; the application in adults is still experimental. The diet consists mainly of fats, a sufficient quantity of protein and a small amount of carbohydrate. From former studies, it is known that the diet is effective in a third to a half of the patients. [1] [2] [3] The goal of KD is to reduce seizure frequency and seizure severity. For a long time it was thought that this effect was primarily due to a rise in the level of ketones which are formed by the breakdown of the large amount of fat in the diet. Fat is consumed in the form of triglycerides which are broken down to fatty acids. In the mitochondria, these fatty acids are degraded by beta-oxidation to acetyl-CoA. Normally acetyl-CoA is used in the Krebs cycle to produce energy (ATP) which requires the presence of oxaloacetate. During KD the amount of acetyl-CoA exceeds the supply of oxaloacetate, and the resulting acetyl-CoA excess is diverted to an alternative pathway in the mitochondria which forms acetoacetic acid (AcAc), BHB and acetone, known collectively as ketone bodies. These can be used by the brain as a form of energy instead of glucose. See Fig. 1 . 4 In clinical practise, ketosis is measured in two different ways: BHB is measured in blood obtained by finger-prick and the level of ketones (mainly AcAc and a small amount of acetone) can be assessed in the urine. BHB in blood seems to correlate better with the amount of ketones in the brain. 15 Clinically, ketosis in the urine is usually used to monitor the diet, [16] [17] [18] probably as this is less invasive. The current view is that ketosis achieves seizure reduction. Whether this is due to a direct inhibiting action of ketones is not clear. Acetone and acetoacetate have been found to inhibit seizures in animal studies. 5, 6 On the other hand, beta-hydroxybutyrate (BHB) does not seem to have an anti-convulsive capability 5 and none of the ketones have an influence on synaptic transmission. 7 In relating BHB to seizure reduction, some researchers found that a certain amount of BHB was needed for efficacy, [8] [9] [10] [11] but others found no relationship. [12] [13] [14] We investigated whether ketosis correlates with seizure reduction in our population. In order to establish the preferred Purpose: To investigate whether it is better to use blood beta-hydroxybutyrate (BHB) or urinary ketones to monitor ketogenic diet (KD). Method: In 33 patients on KD we measured ketosis in two different ways. At the 3-monthly visits to the clinic we measured BHB in capillary blood obtained by finger-prick and the level of ketones in the urine using a urine dipstick. If the patient was able to collect urine, the urinary ketones were also measured every day at home. We compared the degree of ketosis with seizure reduction. Results: BHB measured during the 3-monthly visits correlated with seizure reduction at 3 and 6 months (p = 0.037 and 0.019, respectively). Urinary ketones measured at the same time did not correlate at any visit. The averaged values of the daily measured ketones in the urine did not correlate either. Conclusions: BHB correlates better with seizure reduction than do ketones in urine. It is, therefore, better to use BHB to monitor KD even if BHB is measured less frequently than urinary ketones.
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method of monitoring KD, we measured ketosis in blood and in urine.
Method

Patients
This study was carried out in Kempenhaeghe, a tertiary epilepsy center in the Netherlands. Since 2005, 33 patients with therapyresistant epilepsy, aged between 1 and 40 years, have been included. Patients were excluded if there were medical contraindications (e.g. fatty acid oxidation disorders, diabetes, prolonged QT syndrome, hypercholesterolemia, liver kidney or pancreas disease) or the expectation that compliance with the diet was not possible because of behavioural or motivational problems. Patients were excluded if they quit the diet within 6 weeks or when the seizure diaries, required to calculate efficacy, were not maintained.
Study design
Patients were admitted to the hospital for a period of 2 weeks to introduce the diet which was administered as described in the Dutch guideline for the ketogenic diet. 19 This guideline does not include a fasting period prior to introduction. Usually the MCT-diet was given. If the heath insurance did not refund the cost of diet products or if tube feeding was administered, the classic diet was initiated or, in adults only, the Atkins diet. In some patients changes were made in the MCT-diet, because of side-effects and other problems encountered during its introduction. Such changes included mixing the MCT and the classic diet. All patients were put on the diet by the same dietician according to the protocol. Seizure frequency was obtained from the diaries. A 3-month baseline was established before embarking on the diet. Reduction was calculated by comparing the number of seizures before and after starting the diet, the starting point being defined as the first change made in the normal diet. In cases with more than 50% reduction, the diet was considered effective. We did not distinguish between the various types of seizures.
Ketosis
At every 3-month visit, ketosis was measured in an earlymorning urine sample and in a blood sample taken between 8.00 and 12.00. Ketosis in urine was measured using a urine dipstick, which reacts mainly with AcAc and partially with the volatile acetone. It does not cross-react with BHB. The dipstick measures ketosis semi-quantitatively, giving values of 0 to 4+ which are related to an amount of 0 to >16 mmol/L. BHB was measured at every visit in capillary blood obtained by a finger-prick using a MediSense Precision Xtra. The sample is applied to the electrochemical test strip producing an electronic current, which can be measured. It has a range of 0-8 mmol/l. We tried to achieve a ketosis of 3+ to 4+ (8-16 mmol/L) in urine and a BHB concentration of 2-4 mmol/L in blood.
At home, ketosis was measured on a daily basis by urine dipstick. Values were recorded and brought along to the outpatient visits every 3 months.
Statistics
Applying the SPSS programme, we related blood BHB and urinary ketones to seizure reduction using the Spearman rank correlation test. We also correlated the semi-quantitative average of ketones in the urine to the seizure reduction when more than 10 samples in 3 months were available. Based on a pilot study of 6 measurements, we estimated a correlation between ketone body assessment in the urine and BHB in blood of 0.7. To exclude values of Pearson's correlation coefficient of <0.4 with a power of 80% and a significance level of 0.05 one-sided, 33 patients were needed. Correlations with p < 0.05 were considered significant.
Results
The present study included 33 patients whose characteristics can be found in Table 1 .
Three months after the start of the study, all patients were still on the diet. At 6, 9 and 12 months there were respectively 22, 11 and 10 patients on the diet. At 3 and 6 months, respectively 5 and 6 patients showed a seizure reduction of more than 50%. Of the 33 patients included, 8 achieved a seizure reduction of more than 50% (at 3 or 6 months) which means that in this study KD was effective in 24% of the patients. Once the diet became effective no relapse was seen in any of the patients.
When we correlated the ketosis measured at the visits with seizure reduction, we found a significant correlation for BHB in the capillary blood at 3 and 6 months (p = 0.02 and 0.01), see Table 2 , Figs. 2 and 3 . Interestingly, the one patient in this study who reached complete seizure reduction on KD had a BHB comparable to those without seizure improvements. There was no correlation found with ketones measured in the urine during these visits (p = 0.44 at 3 months and p = 0.37 at 6 months). At 9 and 12 months, we did not find any significance for either test (data not shown).
Normally the diet is not monitored on the basis of only one sample of urine ketosis; the ketosis measured at home is also taken into account. We, therefore, correlated the seizure reduction with the average of all the values measured by the patients at home. 25 patients at 3 months and 17 patients at 6 months had measured the ketosis frequently. But the average of several measurements of ketones in the urine did not correlate with the reduction at any time, Figs. 4 and 5.
Discussion
In this study we show that BHB correlates better with seizure reduction than urinary ketones. Even the average ketosis of several urine samples, measured at home, did not correlate with seizure reduction. BHB is, therefore, more useful in patients on KD. Gilbert et al. came to the same conclusion as did Likhodii et al. when studying KD in rats. 8, 11 Clinically, the urine dipstick is used more often to monitor KD, but our study tends to support the use of BHB rather than urine. A ketosis found in the urine only indicates compliance but it is not a value to aim for in terms of efficacy. Furthermore, fewer measurements of BHB might be required to evaluate the degree of ketosis, as only one value of BHB in 3 months already correlates with seizure reduction. We were not able to collect BHB and urine samples in all 33 patients. Some patients were not able to measure ketosis in the urine every day because of incontinence. There is no reason to consider the ketosis would be different in the excluded patients. Nor were we able to measure BHB at a fixed time due to the fact that most patients using the KD have complex epileptic disorders and are often mentally retarded. All measurements were, however, carried out in the morning. Since the amount of BHB varies during the morning, this might have influenced the level, but as this is the case in both non-responders and in responders, bias may be less likely to have occurred. The correlation with BHB was not found at 9 and 12 months, possibly due to the small number of patients in the study at that time, but Gilbert et al. came to the same conclusion. 8 We can only speculate that this indicates that BHB is not the ultimate parameter for monitoring the KD-also, the only patient who became seizurefree had a low level of BHB. But there is as yet no better parameter available. The efficacy in this study was 24%, which is low compared to other KD studies. [1] [2] [3] Bias may be present because caregivers may have been more eager to complete the seizure diary after the start of the KD as compared to the preceding period (baseline period). In addition, adults were also included in this study, and efficacy might be lower in adults compared to children. We did not stratify for the form of KD (e.g. MCT, classical, Atkins), therefore, we do not know whether ketosis is less well correlated to seizure reduction in one diet compared to another. However, since ketosis was measured and the results were used in the same way in all KD, conclusions drawn in this paper are applicable to all KD.
We did not stratify for the different age groups either and therefore do not know whether ketosis in adults relates differently to seizure control compared to ketosis in children. This is due to the limited number of patients included in this study and the wide agerange. Clinicians do, however, try to reach the same level of ketosis in adults as they do in children and therefore this difference is probably not that important for the aim of the study.
In the present study we showed that infrequent BHB assessment can be used instead of daily ketone assessments in urine to monitor KD. Under certain circumstances, it shows even better correlation with seizure reduction.
